Brief: Biocartis Group Q1 EBITDA Loss Of EUR 8.4 Mln

Biocartis NV

20/04/2023 06:25

April 20 (Reuters) - Biocartis Group NV  BCART.BR :
    * Q1 GROSS MARGIN ON PRODUCTS OF 37%
    * Q1 EBITDA OF EUR -8.4M
    * BIOCARTIS RECONFIRMS ITS 2023 GUIDANCE
    * Q1 PRODUCT RELATED REVENUE OF EUR 10.8M, UP 2%
YEAR-ON-YEAR
    * 2023 OUTLOOK: PRODUCT RELATED REVENUES8 OF BETWEEN EUR 55M
AND
EUR 60M
    * Q1 GROSS PROFIT ON PRODUCT SALES OF EUR 3.8M (Q1 2022: EUR
3.5M)
    * 2023 OUTLOOK: A GROSS MARGIN ON PRODUCT SALES OF BETWEEN
40% AND
45%
    * OUTLOOK 2023: EBITDA OF BETWEEN EUR -25M AND EUR -28M

Source text for Eikon:  ID:nGNE1fTZ27 
Further company coverage:  BCART.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587696600;))